The 1942 publication by Jules Freund and Katherine McDermott concerning guinea pig immunization using killed tubercle bacilli established a critical methodology in immunology. This research defined the utility of adjuvants in enhancing immune responses, marking a significant transition in how vaccines and biological agents are developed, tested, and utilized within modern clinical practice.
Early Education and Military Service
Born in Budapest in 1890, Jules Freund completed his primary medical training at Eötvös Loránd University. He attained his M.D. at age 23. His professional life began amidst the instability of the early twentieth century, serving as a medical interne within the Austrian Army from 1913 to 1914. Following the start of hostilities, he returned to his university as a Commissioner for Hygiene. By 1920, he held the position of assistant professor in Preventive Medicine and earned a Certificate of Public Health. In 1922, he transitioned to the Department of Hygiene at the Medical School in Hamburg.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Research and Immunological Contributions
Freund later established his career in the United States, where his work on immune response acceleration became his primary scientific contribution. His experiments, which utilized horse serum combined with killed tubercle bacilli, provided the basis for the substance now referred to as Freund's adjuvant. This research proved instrumental in increasing the effectiveness of antigens, serving as a foundation for subsequent immunization strategies. The Journal of Immunology documented these experiments as a landmark development within the field, shifting standard laboratory practices for vaccine formulation.
Professional Recognition and Legacy
The scientific community acknowledged his influence through the 1959 Albert Lasker Award for Basic Medical Research. He shared this honor with Albert Coons for their respective, independent advancements in the field. His career concluded in the United States, where he died in 1960 at the age of 70. His professional trajectory reflects the broader shift in twentieth-century medicine, where standardized laboratory investigation and public health initiatives became the primary drivers of reduced mortality rates.
Fast facts
- Born: 1890, Budapest
- Died: 1960, United States
- Citizenship: United States
- Education: Eötvös Loránd University
- Key Publication: 1942 paper with Katherine McDermott
- Awards: 1959 Albert Lasker Award for Basic Medical Research
Questions readers ask
What is Freund's adjuvant?
It is an immunological substance, developed through research with killed tubercle bacilli, used to enhance the body's immune response to antigens.
Where did Jules Freund receive his medical degree?
He earned his medical degree from Eötvös Loránd University in Budapest.
Achievements
- Albert Lasker Award for Basic Medical Research — 1959
